Cargando…
Efficacy and Safety of Daclatasvir in Hepatitis C: An Overview
Hepatitis C virus (HCV) infection is a growing public health concern, with 184 million people infected worldwide. During the past decade, interferon has been the backbone of HCV treatment, even though it remains far from ideal. The latest development of the new direct antivirals has drastically chan...
Autores principales: | Gamal, Nesrine, Gitto, Stefano, Andreone, Pietro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225154/ https://www.ncbi.nlm.nih.gov/pubmed/28097103 http://dx.doi.org/10.14218/JCTH.2016.00038 |
Ejemplares similares
-
Safety and efficacy of daclatasvir in the management of patients with chronic hepatitis C
por: Manolakopoulos, Spilios, et al.
Publicado: (2016) -
Daclatasvir: potential role in hepatitis C
por: Lee, Choongho
Publicado: (2013) -
Update on Alcohol and Viral Hepatitis
por: Gitto, Stefano, et al.
Publicado: (2014) -
Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection
por: Nam, Hee Chul, et al.
Publicado: (2016) -
Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection
por: Xue, Yan, et al.
Publicado: (2017)